95 related articles for article (PubMed ID: 21707193)
1. Naloxone and rimonabant reduce the reinforcing properties of exercise in rats.
Rasmussen EB; Hillman C
Exp Clin Psychopharmacol; 2011 Dec; 19(6):389-400. PubMed ID: 21707193
[TBL] [Abstract][Full Text] [Related]
2. Effects of 2-AG on the reinforcing properties of wheel activity in obese and lean Zucker rats.
Smith SL; Rasmussen EB
Behav Pharmacol; 2010 Jul; 21(4):292-300. PubMed ID: 20512031
[TBL] [Abstract][Full Text] [Related]
3. Effects of rimonabant on behavior maintained by progressive ratio schedules of sucrose reinforcement in obese Zucker (fa/fa) rats.
Rasmussen EB; Huskinson SL
Behav Pharmacol; 2008 Oct; 19(7):735-42. PubMed ID: 18797250
[TBL] [Abstract][Full Text] [Related]
4. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.
Maccioni P; Pes D; Carai MA; Gessa GL; Colombo G
Behav Pharmacol; 2008 May; 19(3):197-209. PubMed ID: 18469537
[TBL] [Abstract][Full Text] [Related]
5. Rimonabant reduces the essential value of food in the genetically obese Zucker rat: an exponential demand analysis.
Rasmussen EB; Reilly W; Buckley J; Boomhower SR
Physiol Behav; 2012 Feb; 105(3):734-41. PubMed ID: 22019829
[TBL] [Abstract][Full Text] [Related]
6. Synergistic efects of opioid and cannabinoid antagonists on food intake.
Kirkham TC; Williams CM
Psychopharmacology (Berl); 2001 Jan; 153(2):267-70. PubMed ID: 11205430
[TBL] [Abstract][Full Text] [Related]
7. Effects of cannabinoid drugs on the reinforcing properties of food in gestationally undernourished rats.
Wakley AA; Rasmussen EB
Pharmacol Biochem Behav; 2009 Nov; 94(1):30-6. PubMed ID: 19602424
[TBL] [Abstract][Full Text] [Related]
8. The effects of anorexic drugs on free-fed rats responding under a second-order FI15-min (FR10:S) schedule for high incentive foods.
Evenden J; Ko T
Behav Pharmacol; 2007 Feb; 18(1):61-9. PubMed ID: 17218798
[TBL] [Abstract][Full Text] [Related]
9. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
Solinas M; Goldberg SR
Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
[TBL] [Abstract][Full Text] [Related]
10. FAAH inhibitor, URB-597, promotes extinction and CB(1) antagonist, SR141716, inhibits extinction of conditioned aversion produced by naloxone-precipitated morphine withdrawal, but not extinction of conditioned preference produced by morphine in rats.
Manwell LA; Satvat E; Lang ST; Allen CP; Leri F; Parker LA
Pharmacol Biochem Behav; 2009 Nov; 94(1):154-62. PubMed ID: 19698735
[TBL] [Abstract][Full Text] [Related]
11. Wheel running exercise attenuates vulnerability to self-administer nicotine in rats.
Sanchez V; Lycas MD; Lynch WJ; Brunzell DH
Drug Alcohol Depend; 2015 Nov; 156():193-198. PubMed ID: 26433561
[TBL] [Abstract][Full Text] [Related]
12. The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716.
Gallate JE; McGregor IS
Psychopharmacology (Berl); 1999 Mar; 142(3):302-8. PubMed ID: 10208323
[TBL] [Abstract][Full Text] [Related]
13. Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats.
Gallate JE; Mallet PE; McGregor IS
Psychopharmacology (Berl); 2004 Apr; 173(1-2):210-6. PubMed ID: 14663553
[TBL] [Abstract][Full Text] [Related]
14. Reinforcement of wheel running in BALB/c mice: role of motor activity and endogenous opioids.
Vargas-Pérez H; Sellings LH; Paredes RG; Prado-Alcalá RA; Díaz JL
J Mot Behav; 2008 Nov; 40(6):587-93. PubMed ID: 18980911
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute low-dose combined treatment with naloxone and AM 251 on food intake, feeding behaviour and weight gain in rats.
Tallett AJ; Blundell JE; Rodgers RJ
Pharmacol Biochem Behav; 2009 Jan; 91(3):358-66. PubMed ID: 18755211
[TBL] [Abstract][Full Text] [Related]
16. Contextual renewal of nicotine seeking in rats and its suppression by the cannabinoid-1 receptor antagonist Rimonabant (SR141716A).
Diergaarde L; de Vries W; Raasø H; Schoffelmeer AN; De Vries TJ
Neuropharmacology; 2008 Oct; 55(5):712-6. PubMed ID: 18588903
[TBL] [Abstract][Full Text] [Related]
17. Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).
Cohen C; Perrault G; Griebel G; Soubrié P
Neuropsychopharmacology; 2005 Jan; 30(1):145-55. PubMed ID: 15292905
[TBL] [Abstract][Full Text] [Related]
18. Differential response to a selective cannabinoid receptor antagonist (SR141716: rimonabant) in female mice from lines selectively bred for high voluntary wheel-running behaviour.
Keeney BK; Raichlen DA; Meek TH; Wijeratne RS; Middleton KM; Gerdeman GL; Garland T
Behav Pharmacol; 2008 Dec; 19(8):812-20. PubMed ID: 19020416
[TBL] [Abstract][Full Text] [Related]
19. Blockade of the cannabinoid CB1 receptor and alcohol dependence: preclinical evidence and preliminary clinical data.
Maccioni P; Colombo G; Carai MA
CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):55-9. PubMed ID: 20201816
[TBL] [Abstract][Full Text] [Related]
20. Naloxone facilitates appetitive extinction and eliminates escape from frustration.
Norris JN; Pérez-Acosta AM; Ortega LA; Papini MR
Pharmacol Biochem Behav; 2009 Nov; 94(1):81-7. PubMed ID: 19660490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
